Approval · Notice of Compliance 26678 · 2021
FLAGYL: Notice of Compliance 26678
Issued September 17, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26678
- Date
- September 17, 2021
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph (PM) with safety information regarding suicidal ideation and vertigo based on the latest Company Core Data Sheets (CCDS), and to convert the PM into the 2020 PM format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLAGYL | Not yet assigned | — |
Medicinal ingredients
- METRONIDAZOLE 10 PER